Eigenbrodt, Anna K. http://orcid.org/0000-0001-5031-8971
Ashina, Håkan
Khan, Sabrina http://orcid.org/0000-0002-0953-5701
Diener, Hans-Christoph http://orcid.org/0000-0002-6556-8612
Mitsikostas, Dimos D.
Sinclair, Alexandra J. http://orcid.org/0000-0003-2777-5132
Pozo-Rosich, Patricia http://orcid.org/0000-0003-0796-4702
Martelletti, Paolo http://orcid.org/0000-0002-6556-4128
Ducros, Anne http://orcid.org/0000-0001-5560-5013
Lantéri-Minet, Michel
Braschinsky, Mark http://orcid.org/0000-0002-3457-0242
del Rio, Margarita Sanchez
Daniel, Oved http://orcid.org/0000-0002-8232-9138
Özge, Aynur http://orcid.org/0000-0003-2797-2398
Mammadbayli, Ayten
Arons, Mihails http://orcid.org/0000-0002-3888-2630
Skorobogatykh, Kirill http://orcid.org/0000-0002-1279-9548
Romanenko, Vladimir
Terwindt, Gisela M.
Paemeleire, Koen http://orcid.org/0000-0001-8103-3899
Sacco, Simona http://orcid.org/0000-0003-0651-1939
Reuter, Uwe http://orcid.org/0000-0002-8527-0725
Lampl, Christian
Schytz, Henrik W. http://orcid.org/0000-0002-6262-2986
Katsarava, Zaza http://orcid.org/0000-0002-9932-1159
Steiner, Timothy J. http://orcid.org/0000-0002-1882-4337
Ashina, Messoud
Article History
Accepted: 7 May 2021
First Online: 18 June 2021
Competing interests
: S.K. has been an invited speaker for Novartis. H.-C.D. has received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from Alder, Allergan, Amgen, Electrocore, Ipsen, Lilly, Medtronic, Novartis, Pfizer, Teva and Weber & Weber. Electrocore has provided financial support for his research projects. The German research council (DFG), the German ministry of Education and Research (BMBF) and the European Union support his headache research. He also serves on the editorial boards of <i>Cephalalgia</i> and <i>Lancet Neurology</i>, chairs the clinical guidelines committee of the German Society of Neurology and is a member of the Clinical Trials Committee of the International Headache Society. D.D.M. has received honoraria, research and travel grants from Allergan, Amgen, Biogen, Cefaly, Eli Lilly, Electrocore, Mertz, Novartis, Roche, Sanofi, Specifar and Teva. A.J.S. reports personal fees from Allergan and Novartis, grants from Novartis, and grants and personal fees from Invex Therapeutics. He is a trustee of the board of the International Headache Society and a member of the Council of the European Headache Federation. P.P.-R. has received honoraria as a consultant and speaker for Allergan, Almirall, Biohaven, Chiesi, Eli Lilly, Medlink, Medscape, Neurodiem, Novartis and Teva. Her research group has received research grants from Allergan, AGAUR, la Caixa foundation, EraNET Neuron, FEDER RISC3CAT, Migraine Research Foundation, Instituto Investigación Carlos III, MICINN, Novartis and PERIS, and has received funding for clinical trials from Alder, Amgen, Electrocore, Eli Lilly, Novartis and Teva. She is the founder of www.midolordecabeza.org, a trustee of the board of the International Headache Society and a member of the Council of the European Headache Federation. She is on the editorial board of <i>Revista de Neurologia</i>, an associate editor for <i>Cephalalgia</i>, <i>Frontiers of Neurology</i> and <i>Journal of Headache and Pain</i>. She is also a member of the Clinical Trials Guidelines Committee of the International Headache Society and has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. P.M. has served on advisory boards for Allergan, Lilly, Novartis and Teva. He has received royalties from Springer Nature and travel support from the European Medicines Agency, and serves as Editor-in-Chief for <i>Journal of Headache and Pain</i>. A.D. reports consultant fees from Eli Lilly, Novartis and Teva. She also serves as President of the French Headache Society. M.L.-M. reports personal fees for advisory boards, speaker panels or investigation studies from Allergan, Amgen, Astellas, ATI, BMS, Boehringer, Boston Scientific, CoLucid, Convergence, GlaxoSmithKline, Grunenthal, Lilly, Medtronic, Menarini, MSD, Novartis, Pfizer, ReckittBenckiser, Saint-Jude, Sanofi-Aventis, Teva, UCB and Zambon. M.S.d.R. reports consultant fees as a speaker or participation on advisory boards from Allergan, Eli-Lilly, Novartis and Teva. G.M.T. reports consultant fees from Amgen, Eli Lilly, Novartis and Teva, and has received grant support from the Dutch Brain Foundation, Dutch Heart Foundation, NIH, NOW and ZonMW. K.P. has received honoraria as a speaker and/or consultant, and/or received research support from Allergan, Amgen/Novartis, Autonomic Technologies, Eli-Lilly and Teva. S.S. reports fees as a speaker or consultant for Allergan, Abbott, Eli-Lilly, Novartis and Teva. She is also an associate editor for <i>Stroke</i> and serves as co-editor for <i>Journal of Headache and Pain</i>. U.R. has received consulting fees, speaking or teaching fees and/or research grants from Allergan, Amgen, Autonomic Technologies, CoLucid, ElectroCore and Novartis. H.W.S. has received consultant fees for lectures from Eli-Lilly, Novartis and TEVA. He has received consultant fees for advisory board participation from Balancair and Eli Lilly, and has received funding from Novartis. Z.K. has been a speaker and/or consultant, and/or received research support from Allergan, Amgen/Novartis, Ely-Lilly, Merck and Teva. T.J.S. reports personal fees from Eli Lilly. M.A. has received personal fees from Alder BioPharmaceuticals, Allergan, Amgen, Eli-Lilly, Novartis and Teva. He has been or is currently a principal investigator on clinical trials for Alder, Amgen, ElectroCore, Novartis and Teva. He serves as Associate Editor of <i>Cephalalgia</i>, <i>Headache</i> and <i>Journal of Headache and Pain</i>. He also reports research grants from Lundbeck Foundation, Novo Nordisk Foundation, and Research Foundation of the Capital Region of Denmark. The other authors report no competing interests.